|
|
1st World Congress on
Controversies in Ophthalmology (COPHy)
Clarion Congress Hotel, Prague, Czech Republic March 4-7, 2010 |
|
| |
| Scientific Program |
 |
|
|
|
Hall A |
|
|
|
|
|
|
SURGICAL RETINA I: MACULAR SURGERY |
|
08:30-10:00 |
|
| Chairperson: |
J. Moisseiev, Israel |
| Moderators: |
A. Augustin, Germany |
|
Capsule: |
Debates in macular surgery |
|
|
|
|
08:30-09:15
08:30-08:45
08:45-09:00
09:00-09:15 |
Discussion |
|
|
|
|
09:15-10:00
09:15-09:30
09:30-10:00 |
Panel Discussion: THE SURGICAL MANAGEMENT OF VARIOUS MACULAR PATHOLOGIES
Moderator: J. Moisseiev, Israel
Panel: A. Augustin, Germany; W. Mieler, USA; J. Nawrocki, Poland
P. Dugel, USA
(2) Panel discussion:
(a) Serous macular detachment from an optic pit
(b) Full thickness and lamellar macular holes, epiretinal membranes (ERMS), vitreomacular traction (VMT) syndrome
(c) Persistent subretinal fluid after buckling for retinal detachment (RD)
|
|
|
|
|
10:00-10:30 |
Coffee Break |
|
|
|
|
|
RETINA SYMPOSIUM: NEW TREATMENT PARADIGMS IN RETINAL DISEASE
Sponsored by Allergan |
| Chairpersons: |
G. Coscas, France & A. Lowenstein, Israel |
| |
|
|
10:30-10:33
|
Introduction & Welcome
Chairpersons |
| |
|
|
10:33-10:45
10:45-10:57
10:57-11:09
11:09-11:21
11:21-11:33
11:33-11:45 |
Diagnosis in retinal disease: What are the different horizons?
W. Drexler, Austria
Inflammatory markers in retinal disease
J. Ambati, USA
Steroid differentiation in retinal disease
B. Kupperman, USA
A. Lowenstein, Israel
OZURDEX® in uveitis
S. Lightman, USA
Combination treatment in age-related macular disease (AMD)
A. Augustin, Germany |
| |
|
|
11:45-12:00
|
Panel Discussion: MANAGEMENT OF RETINAL DISEASE
Moderators: G. Coscas, France & A. Lowenstein, Israel
Panel: J. Ambati, USA; A. Augustin, Germany; W. Drexler, Austria; B. Kupperman, USA;
S. Lightman, USA
|
|
|
|
|
12:30-13:30 |
Lunch Break |
|
|
|
|
|
MEDICAL RETINA I: IS THERE REALLY AN IMPACT OF CATARACT SURGERY ON RETINAL DISEASE? |
|
13:30-15:30 |
|
| Chairperson: |
A. Augustin, Germany |
| Moderator: |
A. Pollack, Israel |
|
Capsule: |
Is there still a question as to whether cataract surgery can impact retinal disease? |
|
|
|
|
13:30-14:15
13:30-13:45
13:45-14:00
14:00-14:15 |
Discussion |
|
|
|
|
14:15-15:00
14:15-14:30
14:30-14:45
14:45-15:00 |
Discussion |
|
|
|
|
15:00-15:30 |
Panel Discussion: CONTROVERSIAL CASES WITH RETINA AND CATARACT
Moderator: B. Kupperman, USA
Panel: A. Augustin, Germany; S. Bressler, USA; P. Dugel, USA; A. Loewenstein, Israel;
A. Pollack, Israel
(1) How should post-surgical cystoid macular edema be treated? First line therapy: What if topical nonsteroidal and topical steroidal drops are not working?
(2) Lattice degeneration prior to cataract surgery: Should prophylactic laser be used?
(3) Diabetic retinopathy and cataract: Combined surgery vs. cataract performed separately
|
|
|
|
|
15:30-16:00 |
Coffee Break |
|
|
|
|
|
SURGICAL RETINA II: CHANGING TRENDS IN VITREORETINAL SURGERY |
|
16:00-18:00 |
|
| Chairperson: |
J. Moisseiev, Israel |
| Moderators: |
A. Augustin, Germany |
|
Capsule: |
Retinal surgery techniques are continuously evolving |
|
|
|
|
16:00-16:45
16:00-16:15
16:15-16:30
16:30-16:45 |
Discussion |
|
|
|
|
16:45-17:30
16:45-17:00
17:00-17:15
17:15-17:30 |
Debate: SURGERY FOR DIABETIC MACULOPATHY
Vitrectomy for diabetic maculopathy: W. Mieler, USA
Discussion |
|
|
|
|
17:30-18:00 |
Panel Discussion: CONTROVERSIAL CASES IN RETINAL DETACHMENT
Moderator: Z. Gregor, UK
Panel: A. Augustin, Germany; P. Dugel, USA; F. Kuhn, USA; J. Moisseiev, Israel; W. Mieler, USA; J. Nawrocki, Poland
(1) What is the role of relaxing retinotomies in severe proliferative vitreoretinopathy (PVR)?
(2) How should retinal detachment from colobomas (including optic pits) be managed?
|
|
|
|
|
Hall B |
|
| |
|
|
|
GLAUCOMA I: MANAGEMENT OF GLAUCOMA |
|
08:30-10:00 |
|
| Chairpersons: |
H.D. Jampel, USA & A. Heijl, Sweden |
|
Capsule: |
When to treat and how to test? |
|
|
|
|
08:30-09:00
08:30-08:40
08:40-08:50
08:50-09:00 |
Discussion |
|
|
|
|
09:00-09:30
09:00-09:10
09:10-09:20
09:20-09:30 |
Discussion |
|
|
|
|
09:30-10:00
09:30-09:40
09:40-09:50
09:50-10:00
|
CONTROVERSIAL CASES REGARDING VARIOUS TOPICS IN GLAUCOMA
Prostaglandin analogues in the setting of macular edema: L. Rossetti, Italy
Panel discussion including all speakers
|
|
|
|
|
10:00-10:30 |
Coffee Break |
|
|
|
|
|
NEURO-OPHTHALMOLOGY I: PSEUDOTUMOR CEREBRI AND OTHER PATHOLOGIES |
|
10:30-12:30 |
|
| Chairpersons: |
A. Safran, Switzerland & A.G. Lee, USA |
|
Capsule: |
Pseudotumor cerebri remains a diagnostic and treatment challenge |
|
|
|
|
10:30-11:30
10:30-10:50
10:50-11:10
11:10-11:30 |
Debate: WHAT IS THE BEST MANAGEMENT FOR PSEUDOTUMOR CEREBRI?
Medical: P. Savino, USA
Discussion |
|
|
|
|
11:30-12:30
|
Panel Discussion: CONTROVERSIAL CASES REGARDING IDIOPATHIC INTRACRANIAL HYPERTENSION AND OTHER
Moderator: A. Kesler, Israel
Panel: A.G. Lee, USA; N.R. Miller, USA; A. Safran, Switzerland; P. Savino, USA
(1) Magnetic resonance vengraphy (MRV) or CT venography for presumed idiopathic intracranial hypertension?
(2) Should stenting be offered to patients with presumed idiopathic intracranial hypertension and venous sinus thrombosis?
(3) Does radiation therapy improve thyroid eye disease?
(4) Does a patient with Horner Syndrome require pharmacologic testing to localize the lesion?
|
|
|
|
|
12:30-13:30 |
Lunch Break |
|
|
|
|
|
CATARACT I: CATARACT SURGERY |
|
13:30-15:30 |
|
| Chairpersons: |
E. Assia, Israel & W.J. Stark, USA |
|
Capsule: |
Albeit cataract being the most common surgical procedure in ophthalmology, there are still open questions |
|
|
|
|
13:30-14:30
13:30-13:40
13:40-13:50
13:50-14:00
14:00-14:15
14:15-14:30 |
Debate: PRESBYOPIA CORRECTION IOLs
Multifocal IOLs: M. Pioviella, Italy
Accommodating IOLs: B. Malyugin, Russia
Monovision: D. Sachs, Israel
Discussion |
|
|
|
|
14:30-15:00
14:30-14:40
14:40-14:50
14:50-15:00 |
Debate: CLEAR LENS EXTRACTION: IS IT ETHICAL?
Probably not: J. Alio, Spain
Discussion |
|
|
|
|
15:00-15:30
15:00-15:07
15:07-15:15
15:15-15:23
15:23-15:30 |
VARIOUS TOPICS REGARDING MICRO-INCISION CATARACT SURGERY (MICS)
Moderator: S. Arshinoff, Canada
(1) MICS: Technique and lenses
(2) Technique and instruments, clear corneal incision: Temporal, superior, oblique?
|
|
|
|
|
15:30-16:00 |
Coffee Break |
|
|
|
|
|
CATARACT II: CATARACT IN SPECIAL SITUATIONS |
|
16:00-18:00 |
|
| Chairpersons: |
J. Alio, Spain & B. Malyugin, Russia |
|
Capsule: |
Despite increasing experience the best intraocular lenses (IOLs) for cataracts remains controversial |
|
|
|
|
16:00-16:45
16:00-16:10
16:10-16:20
16:20-16:30
16:30-16:45 |
Debate: SMALL PUPIL: SURGICAL OPTIONS
Papillary rings: B. Malyugin, Russia
Discussion |
|
|
|
|
16:45-17:30
16:45-17:00
17:00-17:15
17:15-17:30 |
Debate: ASTIGMATIC CORRECTION DURING CATARACT SURGERY?
Yes, Cataract surgery is in any event a refractive surgery: W.J. Stark, USA
Not a must, astigmatic keratotomy (AK)/limbal relaxing incision (LRI) is not accurate and harbor increased risks, and bioptics and toric IOLs are expensive: M. Piovella, Italy
DIscussion |
|
|
|
|
17:30-18:00
17:30-17:40
17:40-17:50
17:50-18:00 |
Debate: SIMULTANEOUS MANAGEMENT OF BILATERAL CATARACTS
Simultaneous surgery is OK: S. Arshinoff, Canada
Discussion
|
|
|
| Hall C |
|
| |
|
| Session 8 |
RETINOBLASTOMA |
| 08:30-10:00 |
|
| Chairpersons: |
F. Munier, Switzerland & L. Zografos, Switzerland |
|
Capsule: |
Retinoblastoma: There are still debates regarding management |
|
|
|
08:30-09:00
08:30-08:37
08:37-08:43
08:43-08:50
08:50-09:00 |
Debate: TREATMENT OF ADVANCED (GROUP D AND E) RETINOBLASTOMA
Chairperson: L. Zografos, Switzerland
Discussion |
|
|
|
09:00-09:30
09:00-09:10
09:10-09:20
09:20-09:30 |
Debate: BRACHYTHERAPY FOR THE TREATMENT OF RETINOBLASTOMA
Chairperson: B. Damato, UK
|
| |
|
|
09:30-10:00
09:30-09:40
09:40-09:50
09:50-10:00
|
Debate: PROTON BEAM VS. EXTERNAL BEAM RADIOTHERAPY FOR RETINOBLASTOMA
Chairperson: F. Munier, Switzerland
Proton beam irradiation: L. Zografos, Switzerland
Discussion
|
|
|
| 10:00-10:30 |
Coffee Break |
| |
|
| Session 9 |
CORNEA DISEASE II: KERATOPLASTY AND KERATOCONUS |
| 10:30-12:30 |
|
| Chairpersosn: |
W.J. Stark, USA |
|
Capsule: |
Many new techniques for keratoplasty have evolved! |
| |
|
|
10:30-11:30
10:30-10:50
10:60-11:10
11:10-11:30
11:30-11:50
11:50-12:30
|
Discussion
Lecture: WHAT IS THE BEST TREATMENT FOR PROGRESSIVE KERATOCONUS?
J. Alio, Spain
Discussion: J. Alio, Spain; W.J. Stark, USA
|
|
|
| 12:30-13:30 |
Lunch Break |
|
|
| Session 10 |
OCULOPLASTICS I: LACRIMAL SYSTEM DISORDERS |
| 13:30-15:30 |
|
| Chairpersons: |
G. Rose, UK & D. Paridaens, The Netherlands |
| Capsule: |
Oculoplastic surgery is a rapidly-developing field, but many issues in the medical and surgical management of patients are still controversial |
|
|
|
13:30-13:55
13:30-13:37
13:37-13:45
13:45-13:55 |
Discussion |
|
|
|
13:55-14:20
13:55-14:03
14:03-14:10
14:10-14:20 |
Discussion |
|
|
|
14:20-14:45
14:20-14:27
14:27-14:35
14:35-14:45 |
Discussion |
|
|
| 14:45-15:30 |
Panel Discussion: CONTROVERSIES IN LIDS AND LACRIMAL
Moderator: D. Verity, UK
Panel: J. Dickinson, UK; C. Hintschich, Germany; D. Paridaens, The Netherlands;
G. Rose, UK; N. Rosen, Israel, U. Schaudig, Germany
(1) One-stitch vs. three-stitch ptosis correction
(2) Should congenital lacrimal fistulae have a DCR as well as fistula excision?
(3) Mohs tumor resection should be used for all tumors?
(4) How soon should DCR be performed after acute dacryocystitis?
(5) Should posterior approach ptosis repair be "retired" from service?
|
|
|
| 15:30-16:00 |
Coffee Break |
|
|
|
|
OCULOPLASTICS II: ORBITS AND SOCKET DISORDERS |
|
16:00-18:00 |
|
| Chairpersons: |
J. Dickinson, UK & C. Hintschich, Germany |
| Capsule: |
Expert views in orbital diseases |
|
|
|
16:00-16:25
16:00-16:07
16:07-16:15
16:15-16:25 |
Discussion |
|
|
|
16:25-16:50
16:25-16:33
16:33-16:40
16:40-16:50 |
Discussion |
|
|
|
16:50-17:15
16:50-16:57
16:57-17:05
17:05-17:15 |
Discussion |
| |
|
| 17:15-18:00 |
Panel Discussion: CONTROVERSIES IN ORBITS AND SOCKETS
Moderator: U. Schaudig, Germany
Panel: J. Dickinson, UK; C. Hintschich, Germany; D. Paridaens, The Netherlands;
G. Rose, UK; N. Rosen, Israel; D. Verity, UK
(1) Is radiotherapy valuable in treatment of thyroid eye disease?
(2) Should possible pleomorphic adenomas be biopsied?
(3) Do porous implants play any role in sockets in this day and age?
(4) Is early repair of blowout fractures essential?
(5) Are dermis-fat grafts an unnecessarily complicated way of socket rehabilitation? |
|
Hall A |
|
|
|
|
|
|
GLAUCOMA SYMPOSIUM: FUTURE GLAUCOMA MANAGEMENT
Sponsored by Allergan |
| Chairpersons: |
A. Heilj, Sweden & P. Denis, France |
| |
|
|
08:30-08:33
|
Introduction and Welcome
Chairpersons |
| |
|
|
08:33-08:48
08:48-09:03
09:03-09:18
09:18-09:33
09:33-09:45 |
Future diagnosis in glaucoma: New possibilities on the horizon
W. Drexler, Austria
How could we change our view on QoL and on priorities in glaucoma?
D. Crabb, UK
Current and future use of progression in clinical glaucoma management
A. Heijl, Sweden
Monotherapy in glaucoma 2010
P. Denis, France
How should we look at combination treatment in the future?
L. Rossetti, Italy |
| |
|
|
09:45-10:00
|
Panel Debate: What can we change now and what must wait for future development/research?
Moderator: A. Heijl, Sweden
Panel: D. Crabb, UK; P. Denis, France; W. Drexler, Austria; L. Rossetti, Italy
|
|
|
|
|
10:00-10:30 |
Coffee Break |
|
|
|
|
|
DME SYMPOSIUM: OPTIMISING THERAPEUTIC BENEFITS OF RANIBIZUMAB IN PATIENTS WITH AMD
Sponsored by Novartis |
| Chairperson: |
N. Bressler, USA |
| |
|
|
10:30-10:40
|
Opening remarks
Chairperson |
| |
|
|
10:40-10:55
10:55-11:10
11:10-11:30
11:30-11:50
11:50-12:05
12:05-12:20
12:20-12:30
|
Safety in neovascular AMD: An in-depth review of ranibizumab
F. Bandello, Italy
Discussion
Evidence-based outcomes evaluation: Can the benefits seen in randomized clinical trials be transferred to the clinic?
N. Bressler, USA
Discussion
Predictors of treatment response: New sub analyses from clinical trials
U. Schmidt-Erfurth, Austria
Discussion
Summary
Chairperson
|
|
|
|
|
12:30-13:30 |
Lunch Break |
|
|
|
|
|
UVEITIS I: TREATMENT STRATEGIES FOR INTRAOCULAR INFLAMMATION |
|
13:30-15:30 |
|
| Chairperson: |
D.A. Jabs, USA |
|
Capsule: |
Intraocular inflammation has new treatment strategies |
|
|
|
|
13:30-14:30
13:30-13:50
13:50-14:10
14:10-14:30 |
Discussion |
|
|
|
|
14:30-15:30
14:30-14:50
14:50-15:10
15:10-15:30 |
Discussion
|
|
|
|
|
15:30-16:00 |
Coffee Break |
|
|
|
|
|
UVEITIS II: TREATMENT OF INFLAMMATORY EYE DISEASE |
|
16:00-18:00 |
|
| Chairperson: |
S. Lightman, UK |
|
Capsule: |
Controversies still exist over the optimal management of inflammatory eye disease |
|
|
|
|
16:00-16:45
16:00-16:15
16:15-16:30
16:30-16:45 |
Discussion |
|
|
|
|
16:45-17:30 |
Panel Discussion: CONTROVERSIAL CASES IN UVEITIS
Moderator: J. Forrester, UK
Panel: N. Archarya, USA; J. Heissigerova, Czech Republic; S. Lightman, UK
(1) What is the role of vitreoretinal surgery in uveitis?
(2) What is the best surgical approach for juvenile rheumatoid arthritis associated cataract?
(3) What is the role of intravitreal steroids in uveitis? |
|
|
|
|
17:30-18:00 |
J. Forrester, UK
|
|
|
|
|
Hall B |
|
|
|
|
|
|
MEDICAL RETINA II: TREATMENT OF DIABETIC RETINOPATHY & DIABETIC MACULAR EDEMA (DME)
|
|
08:30-10:00 |
|
| Chairperson: |
S. Bressler, USA |
| Moderators: |
F. Bandello, Italy & N. Bressler, USA |
|
Capsule: |
Treatments for diabetic macular edema address different pathogenic mechanisms: Do we know how best to utilize our options? |
|
|
|
|
08:30-09:00
08:30-08:40
08:40-08:50
08:50-09:00 |
Debate: WHAT TREATMENT SHOULD BE USED IN CONJUNCTION WITH FOCAL/GRID LASER?
Corticosteroids: B. Kupperman, USA
Anti-vascular endothelial growth factor (VEGF): S. Bressler, USA
Discussion |
|
|
|
|
09:00-09:30
09:00-09:10
09:10-09:20
09:20-09:30 |
|
| |
|
| 09:30-10:00 |
Panel Discussion: CONTROVERSIAL CASES IN PROLIFERATIVE DIABETIC RETINOPATHY (PDR)
Moderator: S. Bressler, USA
Panel: N. Bressler, USA; M. Goldstein, Israel; B. Kupperman, USA; Y. Yassur, Israel
(1) Pan-retinal photocoagulation (PRP) Techniques: Mild scatter or full scatter; Indirect or slit-lamp delivery; Automated mode delivery (e.g., Pascal laser) or manual delivery?
(2) If treating diabetic macular edema with an anti-VEGF drug in the setting of retinal neovascularization, do you also do PRP if there is PDR or wait until the anti-VEGF drug is discontinued?
(3) Advanced high-risk PDR: PRP initially, or PRP with anti-VEGF drugs or anti-VEGF drugs alone, or go right to vitrectomy?
|
|
|
|
|
10:00-10:30 |
Coffee Break |
|
|
|
|
|
NEURO-OPHTHALMOLOGY II: OPTIC NEUROPATHY |
|
10:30-12:30 |
|
| Chairperson: |
A.G. Lee, USA |
|
Capsule: |
Optic neuropathy has many faces and pauses many debates |
|
|
|
|
10:30-11:15
10:30-10:45
10:45-11:00
11:00-11:15 |
Debate: WHAT IS THE BEST MANAGEMENT FOR NONARETERITIC OPTIC NEUROPATHY (NAION)?
Systemic steroids: P. Savino, USA
Aspirin: A. Safran, Switzerland
Avastin: N.R. Miller, USA
Discussion |
|
|
|
|
11:15-12:00
11:15-11:30
11:30-11:45
11:45-12:00 |
Debate: SHOULD A PATIENT WITH ACUTE OPTIC NEURITIS AND WHITE MATTER LESIONS BE TREATED FOR MULTIPLE SCLEROSIS AND HOW?
Yes: A.G. Lee, USA
No: P. Savino, USA
Discussion |
|
|
|
|
12:00-12:30 |
Panel Discussion: CONTROVERSIAL CASES REGARDING SELECTED QUESTIONS IN NEUROOPHTHALMOLOGY
Moderator: P. Savino, USA
Panel: A.G. Lee, USA; N.R. Miller, USA; A. Safran, Switzerland
(1) Should a patient with Giant cell arteritis have a unilateral or bilateral temporal artery biopsy?
(2) Does a patient with NAION need coagulation systemic evaluation?
(3) Do erectile dysfunction drugs cause an ischemic optic neuropathy?
(4) Does amiodarone cause an ischemic optic neuropathy?
(5) Should traumatic optic neuropathy be treated? If so: When and how?
|
|
|
|
|
12:30-13:30 |
Lunch Break |
|
|
|
|
|
MEDICAL RETINA III: NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (AND) AND GEOGRAPHIC ATROPHY |
|
13:30-15:30 |
|
| Chairperson: |
A. Augustin, Germany |
| Moderators: |
S. Bressler, USA & F. Bandello, Italy |
| Capsule: |
Current treatment regimen for neovascular AMD |
| |
|
|
13:30-14:15
13:30-13:40
13:40-13:50
13:50-14:00
14:00-14:15 |
Discussion |
| |
|
|
14:15-15:00
14:15-14:30
14:30-14:45
14:45-15:00 |
Debate: IS THERE ADEQUATE EVIDENCE TO RECOMMEND BEVACIZUMAB OVER RANIBIZUAMB WHEN FINANCES ARE NOT AN ISSUE?
Yes: U. Schmidt-Erfurth, Austria
No: F. Bandello, Italy
Discussion |
| |
|
|
15:00-15:30
15:00-15:10
15:10-15:20
15:20-15:30 |
Debate: IS AUTOFLUORESCENCE NEEDED IN THE MANAGEMENT OF NEOVASCULAR AMD OR GEOGRAPHIC ATROPHY?
Yes: U. Schmidt-Erfurth, Austria
No: S. Bressler, USA
Discussion
|
|
|
|
|
15:30-16:00 |
Coffee Break |
|
|
|
|
|
MEDICAL RETINA IV: MANAGEMENT OF MACULAR EDEMA IN VEIN OCCLUSION |
|
16:00-18:00 |
|
| Chairperson: |
B. Kupperman, USA |
| Moderator: |
A. Augustin, Germany |
| Capsule: |
Treatment modalities of venous occlusive diseases |
| |
|
|
16:00-16:45
16:00-16:10
16:10-16:20
16:20-16:30
16:30-16:45 |
Discussion |
| |
|
|
16:45-17:30
16:45-17:00
17:00-17:15
17:15-17:30 |
Discussion |
| |
|
| 17:30-18:00 |
Panel Discussion: CONTROVERSIAL CASES OF CENTRAL VEIN OCCLUSION WITH NONPERFUSION
Moderator: D. Finkelstein, USA
Panel: F. Bandello, Italy; B. Kupperman, USA
(1) Is a fluorescein angiogram needed?
(2) Should PRP be placed right away?
(3) If edema is being treated with anti-VEGF, and there is iris neovascularization, is PRP also indicated while providing anti-VEGF? When anti-VEGF is discontinued?
(4) Is a medical work-up indicated?
|
|
|
|
|
Hall C |
|
|
|
|
|
|
CATARACT III: CATARACTS IN COMPLICATED OCULAR SITUATIONS AND COMPLICATIONS OF SURGERY |
|
08:30-10:00 |
|
| Chairpersons: |
E. Assia, Israel; W.J. Stark, USA |
|
Capsule: |
A cataract surgeon still faces complex situations and a variety of complications |
|
|
|
|
08:30-09:15
08:30-08:40
08:40-08:55
08:55-09:10
09:10-09:15 |
Debate: SUBLUXATED INTRAOCULAR LENSES
Discussion |
|
|
|
09:15-10:00
09:15-09:25
09:25-09:35
09:35-09:45
09:45-10:00
|
Debate: PREOPERATIVE CARE
Best antibiotic is ceforoxime (the European experience): M. Piovella, Italy
Discussion
|
|
|
|
|
10:00-10:30 |
Coffee Break |
|
|
|
|
|
TUMORS I: UVEAL MELANOMA |
|
10:30-12:30 |
|
| Chairpersons: |
L. Zografos, Switzerland & E. Gragoudas, USA |
|
Capsule: |
Many controversies exist in the treatment of uveal melanoma |
|
|
|
|
10:30-11:30
10:30-10:45
10:45-11:00
11:00-11:15
11:15-11:30 |
Debate: WHAT IS THE BEST CONSERVATIVE MANAGEMENT OF UVEAL MELANOMA?
Chairperson: L. Zografos, Switzerland
Discussion |
|
|
|
|
11:30-12:00
11:30-11:40
11:40-11:50
11:50-12:00 |
Debate: MELANOMA: SHOULD WE PERFORM SYSTEMIC EVALUATION?
Chairperson: J. Pe'er, Israel
Yes: B. Damato, UK
No: E. Gragoudas, USA
Discussion |
|
|
|
|
12:00-12:30
12:00-12:10
12:10-12:20
12:20-12:30 |
Debate: IS IT RECOMMENDED TO PERFORM A FINE NEEDLE ASPIRATION BIOPSY IN UVEAL MELANOMAS BEFORE CONSERVATIVE TREATMENT?
Chairperson: E. Gragoudas, USA
Yes: B. Damato, UK
No: L. Zografos, Switzerland
Discussion
|
|
|
|
|
12:30-13:30 |
Lunch Break |
|
|
|
|
|
PEDIATRIC OPHTHALMOLOGY & STRABISMUS I: STRABISMUS SURGERY |
|
13:30-15:30 |
|
| Chairperson: |
TBA |
|
Capsule: |
What is the optimal surgical treatment of various strabismus conditions? |
|
|
|
|
13:30-14:15
13:30-13:45
13:45-14:00
14:00-14:15 |
Debate: NYSTAGMUS SURGERY
Conservative approach is warranted: TBA
Radical thinking is the best: R. Hertle, USA
Discussion |
|
|
|
|
14:15-15:00
14:15-14:30
14:30-14:45
14:45-15:00 |
Debate: STRABISMUS SURGERY
Minimally invasive: D. Mojon, Switzerland
Invasive: D. Mojon, Switzerland
Discussion |
|
|
|
|
15:00-15:30
15:00-15:10
15:10-15:20
15:20-15:30 |
Discussion
|
|
|
|
|
15:30-16:00 |
Coffee Break |
|
|
|
|
|
TRAUMA I: OPEN GLOBE INJURY |
|
16:00-18:00 |
|
| Chairpersons: |
F. Kuhn, USA & J. Moisseiev, Israel |
|
Capsule: |
Management of open globe injury remains one of the most controversial problems in ophthalmology |
|
|
|
|
16:00-16:45
16:00-16:15
16:15-16:30
16:30-16:45 |
Debate: TIMING OF VITRECTOMY IN POSTERIOR SEGMENT TRAUMA
Discussion |
|
|
|
|
16:45-18:00 |
Panel Discussion: THE MANAGEMENT OF POSTERIOR SEGMENT INJURY: CASE PRESENTATION
Capsule: The panel will discuss the management of intraocular foreign bodies, open globe injury and blunt trauma. Cases and surgical videos will be presented to the panel, and the various dilemmas and treatment options will be thoroughly discussed
Moderators: J. Moisseiev, Israel & F. Kuhn, USA
Panel: A. Augustin, Germany; A. Barak, Israel; J. Nawrocki, Poland
|
| Hall A |
|
| |
|
| Session 22 |
SOCIOECONOMIC AND ETHICAL CONSIDERATIONS: INDUSTRY CONSIDERATIONS |
| 08:30-10:00 |
|
| Chairperson: |
N. Bressler, USA |
|
Capsule:
|
Our management of patient disease depends not only on individual patient condition but also on general socioeconomic situations and upon ethical considerations |
|
|
|
08:30-09:15
08:30-08:45
08:45-09:15
|
Panel discussion: PROS AND CONS REGARDING INDUSTRY INTERACTIONS WITH CONTINUING MEDICAL EDUCATION
Moderator: N. Bressler, USA
Panel: A. Loewenstein, Israel; Z. Gregor, UK, D.A. Jabs, USA
(1) Industry funding of continuing medical education
(2) Is participation in speakers bureaus unprofessional conduct for physicians who participate in continuing medical education? |
| |
|
|
09:15-09:30 |
D. Finkelstein, USA |
| |
|
|
09:30-10:00
09:30-09:40
09:40-09:50
09:50-10:00
|
Debate: SCREENING OF PATIENTS FOR VARIOUS EYE DISEASE
Con: Screening causes vomit syndrome: A.R. Shapira, Israel
Discussion
|
| |
|
| 10:00-10:30 |
Coffee Break |
| |
|
|
|
REFRACTIVE SURGERY I: HOT CONTROVERSIES IN KERATOCONUS AND KERATOECTASIA & ASTIGMATISM CORRECTION |
| 10:30-12:30 |
|
| Chairpersons: |
J. Murta, Portugal & J. Alio, Spain |
|
Capsule: |
Newest concepts in refractive surgery |
| |
|
|
10:30-11:15
|
Panel discussion: CONTROVERSIAL CASES REGARDING TREATMENT OF KERATECSASIA
Moderator: J. Colin, France
Panel: M. Holzer, Germany; G. Kymionis, Greece; J. Murta, Portugal
(1) When should a post-laser-assisted in situ keratomileusis (LASIK) keratoectatic eye be treated?
(2) Should the fellow eye be treated? |
| |
|
|
11:15-12:00
|
Panel discussion: CONTROVERSIAL CASES REGARDING TREATMENT OF MYOPIA
Moderator: J. Alio, Spain
Panel: M. Holzer, Germany; G. Kymionis, Greece
(1) What is the perfect management for myopia: Surface ablation or flap?
(2) What is the best way to perform flap? Mechanical microkeratome or Femtosecond laser? |
| |
|
| 12:00-12:30 |
Panel discussion: CONTROVERSIAL CASES REGARDING ASTIGMATISM CORRECTION
Moderator: J. Alio, Spain
Panel: W.J. Stark, USA; G. Kymionis, Greece; J. Murta, Portugal
(1) How should three diopters of astigmatism be treated?
(2) Relaxing incisions (blade or laser)
(3) Toric IOL
|
| |
|
| Hall B |
|
| |
|
|
|
DIAGNOSIS AND THERAPY OF PEDIATRIC RETINAL DYSTROPHIES
Sponsored by EPOS |
| 08:30-10:00 |
|
|
|
|
Mutation screening of patients with inherited retinal dystrophies: Which method, against what costs, and who will pay?
F. Cremers, The Netherlands
|
|
B. Lorenz, Germany
|
|
The development of AAV vectors for retinal gene therapy: Advantages and limitations
E. Surace, Italy
|
|
Accessibility of retinal degenerations to gene therapy
K. Stieger, Germany
|
|
|
|
|
| 10:00-10:30 |
Coffee Break |
|
|
| Session 25 |
PEDIATRIC OPHTHALMOLOGY & STRABISIMUS II: PEDIATRIC OPHTHALMOLOGY |
| 10:30-12:30 |
|
| Chairpersons: |
K.K. Nischal, UK |
| Capsule: |
Should all adult technologies be applied to children? |
|
|
|
10:30-11:15
10:30-10:45
10:45-11:00
11:00-11:15 |
Debate: REFRACTIVE SURGERY IN CHILDREN
Yes: E. Paysse, USA
No: D. Granet, USA
Discussion |
|
|
|
11:15-12:00
11:15-11:45
11:45-12:00 |
Debate: AVASTIN IN RETINOPATHY OF PREMATURITY
|
| |
|
| 12:00-12:30 |
Panel Discussion: CONTROVERSIAL CASES REGARDING CATARACTS IN CHILDREN
Moderator: K.K. Nischal, UK
Panel: E. Paysse, USA: H. Stolovich, Israel
(1) Should an IOL be implanted?
(2) Should we perform posterior capsulorhexis?
|
|
|
| Hall C |
|
| |
|
| Session 26 |
TRAUMA II: TRAUMATIC CATARACT IN ADULTS AND CHILDREN |
| 08:30-10:00 |
|
| Chairpersons: |
F. Kuhn, USA; J. Moisseiev, Israel |
| Capsule: |
Traumatic eye injury is one of the most controversial problems and requires collaboration of most subfields in ophthalmology |
| |
|
|
08:30-09:00
08:30-08:40
08:40-08:50
08:50-09:00 |
Debate: TRAUMATIC CATARACT IN ADULTS AND CHILDREN
Primary lens removal and IOL implantation: E. Assia, Israel
Discussion |
| |
|
|
09:00-10:00
09:00-09:20
09:20-09:40
09:40-10:00 |
CONTROVERSIAL CAES IN TRAUMA MANAGEMENT
|
| |
|
| 10:00-10:30 |
Coffee Break |
|
|
|
|
WebStudio.co.il